Invirase (saquinavir mesylate) Capsules and Tablets 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 WARNINGS AND PRECAUTIONS QT Interval Prolongation Patients initiating therapy with INVIRASE/ritonavir: An ECG...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts